InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Narachi Michael, 董事. Insider active across 2 companies, notably Ultragenyx Pharmaceutical Inc.. Aggregated, 7 disclosures have been logged. History available since 24 June 2021. The latest transaction was filed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Narachi Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
5,740 股0Common StockSEC:0000950170-25-074665:0
5,345 股0Common StockSEC:0000950170-24-075487:0
3,860 股0Common StockSEC:0001209191-23-035688:0
3,300 股0Common StockSEC:0001209191-22-039565:0
2,145 股0Common StockSEC:0001209191-21-043538:0
721 股Common StockSEC:0001209191-16-095645:0
1,761 股Common StockSEC:0001209191-16-095645:1
7 条申报中的 7 条
About Narachi Michael
Michael Narachi is a Director of Ultragenyx Pharmaceutical Inc. As a board member, he participates in overseeing the company's activities and making strategic decisions. His experience and skills in corporate governance are essential for guiding Ultragenyx Pharmaceutical Inc. in its growth and innovation objectives.
